Records containing: SLE
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-08A Phase 2, Multicenter, Multinational, Randomized, Double-blind, Placebo-Controlled Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Dose Levels of ESK-001 in Adult Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2026-04-06A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2026-03-19A Phase 1b, Open-label, Pilot Study of CLN-978 for the Treatment of Moderate to Severe Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2026-02-23CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Adolescents and Young Adults With Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2026-02-03Clinical Study on the Safety, Efficacy, and Pharmacokinetics of CD19-targeted CAR-T Cell Injection for the Treatment of Autoimmune Diseases Mediated by Autoantibodies.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-02Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-01-23An Open-label, Multi-center, Single-arm Phase 1/2 Study to Assess Tolerability, Safety and Efficacy of CRC01 in Participants With Severe, Refractory Autoimmune Diseases: Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-12-31Pregnancy Outcomes Prior to a Systemic Lupus Erythematosus Diagnosis
-
CLINICAL_TRIALS study record update · 2025-12-18Myocardial Inflammation in Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-12-16A Randomized, Double-blind, Placebo-controlled Phase I/II Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.
-
CLINICAL_TRIALS study record update · 2025-12-10A Phase 1 Study to Evaluate the Efficacy and Safety of AB-101, an Allogeneic Cord Blood- Derived NK-Cell Therapy in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-11-20Safety and Efficacy of ONTO1 in Lupus
-
CLINICAL_TRIALS study record update · 2025-10-02A Clinical Study of the Safety, Efficacy, and Cell Pharmacokinetics of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.
-
CLINICAL_TRIALS study record update · 2025-09-11A Phase I, Open-Label Study to Evaluate the Safety and Tolerability of Subcutaneous Administration of Umbilical Cord Derived - Mesenchymal Stromal Cell Therapy in Addition to Standard of Care as A Treatment For Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-09-02Serum Interleukin-33 (IL-33) Levels and Their Association With Clinical Manifestations in Patients With Systemic Lupus Erythematosus and Lupus Nephritis at Assiut University Hospital
-
CLINICAL_TRIALS study record update · 2025-07-18The Bearing Between Systemic Lupus Erythematosus Severity With Vitamin D Through Treg Cell Entanglement in Pediatric Patients
-
CLINICAL_TRIALS study record update · 2025-04-16Study of the Cardio Renal Effects of SGLT2 Inhibitors Among Diabetic and Non-diabetic Lupus Nephritis Patients
-
CLINICAL_TRIALS study record update · 2025-04-06Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals With Rheumatic Diseases.
-
CLINICAL_TRIALS study record update · 2025-03-28Improving the Assessment of Systemic Lupus Erythematosus Disease Activity
-
CLINICAL_TRIALS study record update · 2025-03-12Assessment of Blood Indices As Predictors of Disease Activity in Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-02-04Evaluating Mental Health Challenges in Juvenile Lupus Erythematosus and Their Caregivers
-
CLINICAL_TRIALS study record update · 2025-01-10Vaccination in Patients With Inflammatory Rheumatic Diseases. The Impact of Anti-rheumatic Treatments on the Immunogenicity of Herpes-zoster Vaccine (Shingrix) and Protection Against Infection (HZ-REUMA)
-
CLINICAL_TRIALS study record update · 2024-10-16A Phase 1b/2a Open Label Dose Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Budoprutug in Adult Participants With Sys-temic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2023-11-07Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2023-07-24Home Monitoring of Fetal Heart Rhythm in Pregnancies of Anti-Ro/SSA Positive Women for the Treatment of Congenital Heart Block (FETAL HOPE)